These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 28240682)

  • 1. Visfatin levels are increased in patients with resistant hypertension and are correlated with left ventricular hypertrophy.
    Ozal E; Sahin I; Bolat I; Pusuroglu H; Avci II; Akgul O; Ornek V; Sürgit O; Yildirim A
    Blood Press Monit; 2017 Jun; 22(3):137-142. PubMed ID: 28240682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship of visfatin levels with insulin resistance and left ventricular hypertrophy in peritoneal dialysis patients.
    Karakan S; Sezer S; Özdemir Acar FN; Haberal M
    Ren Fail; 2012; 34(6):732-7. PubMed ID: 22503095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of 25-Hydroxyvitamin D Levels in Patients with Resistant Hypertension.
    Belen E; Şahin İ; Güngör B; Ayça B; Avcı İİ; Avşar M; Yıldız SS; Akın F; Bozbeyoglu E; Okuyan E
    Med Princ Pract; 2016; 25(1):25-30. PubMed ID: 26278895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uncontrolled hypertension due to volume overload contributes to higher left ventricular mass index in CAPD patients.
    Koc M; Toprak A; Tezcan H; Bihorac A; Akoglu E; Ozener IC
    Nephrol Dial Transplant; 2002 Sep; 17(9):1661-6. PubMed ID: 12198220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ambulatory 24-hour blood pressure monitoring: correlation between blood pressure variability and left ventricular hypertrophy in untreated hypertensive patients.
    Feola M; Boffano GM; Procopio M; Reynaud S; Allemano P; Rizzi G
    G Ital Cardiol; 1998 Jan; 28(1):38-44. PubMed ID: 9493044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is home blood pressure monitoring useful in the management of patients with resistant hypertension?
    Muxfeldt ES; Barros GS; Viegas BB; Carlos FO; Salles GF
    Am J Hypertens; 2015 Feb; 28(2):190-9. PubMed ID: 25143267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship of visfatin levels to inflammatory cytokines and left ventricular hypertrophy in hemodialysis and continuous ambulatory peritoneal dialysis patients.
    Erten Y; Ebinç FA; Ebinç H; Paşaoğlu H; Demirtaş C; Taçoy G; Koç E; Derici U; Reis KA; Bali M; Arinsoy T; Sindel S
    Ren Fail; 2008; 30(6):617-23. PubMed ID: 18661412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic resistant hypertension patterns as predictors of cardiovascular morbidity: a 4-year prospective study.
    Tsioufis C; Kasiakogias A; Kordalis A; Dimitriadis K; Thomopoulos C; Tsiachris D; Vasileiou P; Doumas M; Makris T; Papademetriou V; Kallikazaros I; Bakris G; Stefanadis C
    J Hypertens; 2014 Feb; 32(2):415-22. PubMed ID: 24241057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. True resistant hypertension: is it possible to be recognized in the office?
    Muxfeldt ES; Bloch KV; Nogueira Ada R; Salles GF
    Am J Hypertens; 2005 Dec; 18(12 Pt 1):1534-40. PubMed ID: 16364821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of resistant hypertension: aldosterone antagonists or intensification of diuretic therapy?
    Verdalles U; García de Vinuesa S; Goicoechea M; Macías N; Santos A; Perez de Jose A; Verde E; Yuste C; Luño J
    Nephrology (Carlton); 2015 Aug; 20(8):567-71. PubMed ID: 25818266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevalence of target organ damage and metabolic abnormalities in resistant hypertension].
    Armario P; Oliveras A; Hernández Del Rey R; Ruilope LM; De La Sierra A;
    Med Clin (Barc); 2011 Oct; 137(10):435-9. PubMed ID: 21719041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between gender and clinical characteristics, associated factors, and hypertension treatment in patients with resistant hypertension.
    Hanus KM; Prejbisz A; Gąsowski J; Klocek M; Topór-Mądry R; Leśniak W; Kabat M; Czarnecka D; Kawecka-Jaszcz K; Narkiewicz K; Januszewicz A
    Kardiol Pol; 2017; 75(5):421-431. PubMed ID: 28150289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of olmesartan vs irbesartan on metabolic parameters and visfatin in hypertensive obese women.
    De Luis DA; Conde R; Gonzalez Sagrado M; Aller R; Izaola O; Perez Castrillon JL; Romero E; Castro MJ
    Eur Rev Med Pharmacol Sci; 2010 Sep; 14(9):759-63. PubMed ID: 21061834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blunted sleep-time relative blood pressure decline increases cardiovascular risk independent of blood pressure level--the "normotensive non-dipper" paradox.
    Hermida RC; Ayala DE; Mojón A; Fernández JR
    Chronobiol Int; 2013 Mar; 30(1-2):87-98. PubMed ID: 23039824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D therapy to reduce blood pressure and left ventricular hypertrophy in resistant hypertension: randomized, controlled trial.
    Witham MD; Ireland S; Houston JG; Gandy SJ; Waugh S; Macdonald TM; Mackenzie IS; Struthers AD
    Hypertension; 2014 Apr; 63(4):706-12. PubMed ID: 24420547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood pressure variability and its association with echocardiographic parameters in hypertensive diabetic patients.
    Massierer D; Leiria LF; Severo MD; Ledur Pdos S; Becker AD; Aguiar FM; Lima E; Freitas VC; Schaan BD; Gus M
    BMC Cardiovasc Disord; 2016 Jan; 16():4. PubMed ID: 26747793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Independent association of cognitive dysfunction with cardiac hypertrophy irrespective of 24-h or sleep blood pressure in older hypertensives.
    Hayakawa M; Yano Y; Kuroki K; Inoue R; Nakanishi C; Sagara S; Koga M; Kubo H; Imakiire S; Aoyagi Z; Kitani M; Kanemaru K; Hidehito S; Shimada K; Kario K
    Am J Hypertens; 2012 Jun; 25(6):657-63. PubMed ID: 22421907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between visfatin and HOMA-IR in hypertensive patients, and the effect of antihypertensive drugs on visfatin and HOMA-IR in hypertensive patients with insulin resistance.
    Lan J; Chen X; Chen X; Wang S; Zhang X; Wu K; He S; Peng Y; Jiang L; Li L; Wan L
    Diabetes Res Clin Pract; 2011 Oct; 94(1):71-6. PubMed ID: 21742399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Importance of Resistant Hypertension in Patients With Type 2 Diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study.
    Cardoso CRL; Leite NC; Bacan G; Ataíde DS; Gorgonio LKC; Salles GF
    Diabetes Care; 2020 Jan; 43(1):219-227. PubMed ID: 31619394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left ventricular hypertrophy in hypertension is associated with the insulin resistance metabolic syndrome.
    Lind L; Andersson PE; Andrén B; Hänni A; Lithell HO
    J Hypertens; 1995 Apr; 13(4):433-8. PubMed ID: 7629404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.